• Sulfamonomethoxine: Protocol Advances for Veterinary and Aqu

  2026-04-20

  Sulfamonomethoxine (SMM) delivers proven efficacy in both veterinary and aquaculture research, bridging antibacterial performance with environmental assessment workflows. This article translates cutting-edge degradation and toxicity data into actionable protocols, empowering researchers to maximize SMM’s reliability from bench to environmental monitoring.

• GLP-1 (9-36) Amide: Selective GLP-1 Receptor Antagonism in R

  2026-04-19

  GLP-1 (9-36) amide is a rigorously validated glucagon-like peptide-1 receptor antagonist used in GPCR signaling and metabolic regulation studies. Its unique specificity and handling requirements make it an essential tool for dissecting incretin pathways and investigating type 2 diabetes mechanisms.

• Ginkgo biloba Compound Cocktail Extends Yeast Lifespan via M

  2026-04-18

  This study demonstrates that a network pharmacology-guided cocktail of four Ginkgo biloba compounds—quercetin, rutin, ginkgolide B, and isorhamnetin—synergistically boosts mitochondrial function and extends chronological lifespan in yeast. The findings illuminate the value of multi-component phytochemical strategies for cellular anti-aging research and mitochondrial health.

• Chloroquine Diphosphate: Autophagy Modulation and Cancer Res

  2026-04-17

  Chloroquine diphosphate is a validated autophagy modulator and TLR7/9 inhibitor widely used in cancer research. It demonstrates reproducible G1 phase cell cycle arrest and chemotherapy sensitization, with benchmark IC50 values of 15–40 µM in vitro. APExBIO's A8628 formulation provides robust performance for both in vitro and in vivo applications.

• MG-262 (Z-Leu-Leu-Leu-B(OH)2): Selective Proteasome Inhibito

  2026-04-16

  MG-262 (Z-Leu-Leu-Leu-B(OH)2) is a potent, reversible, cell-permeable inhibitor of proteasome chymotryptic activity, widely used in apoptosis research and cell cycle regulation studies. Its boronic peptide acid structure ensures high selectivity and rapid, reversible binding. This article details MG-262’s mechanism, evidence base, and best practices for experimental use.

• Biotin-XX Tyramide Reagent: Precision Cell Surface Labeling

  2026-04-15

  Biotin-XX Tyramide Reagent (biotin-LC-LC-tyramide) is a membrane-impermeant probe that enables highly selective tyramide signal amplification for cell surface protein labeling. Its extended polyamide linker prevents intracellular diffusion, ensuring robust surface specificity. This product is essential for advanced immunohistochemistry and in situ hybridization workflows requiring enhanced sensitivity.

• Machine Learning Prediction of Lipid Nanoparticles for mRNA

  2026-04-14

  This study pioneers a machine learning approach to predict and optimize lipid nanoparticle formulations for mRNA vaccine delivery, using a curated dataset and experimental validation. Findings highlight the identification of critical ionizable lipid substructures and provide a foundation for rapid, cost-effective virtual screening of mRNA vaccine delivery systems.

• Kitasamycin Efficacy Against Swine Dysentery: Resistance, Me

  2026-04-13

  This study rigorously evaluated kitasamycin, a macrolide antibiotic, for controlling swine dysentery in experimentally infected pigs. The research identifies the prevalence of antimicrobial resistance in Brachyspira hyodysenteriae and outlines the conditions under which kitasamycin retains therapeutic value, with implications for both veterinary and translational resistance research.

• Levofloxacin: Synthetic Fluoroquinolone Antibiotic in Bench

  2026-04-12

  Levofloxacin stands out as a synthetic fluoroquinolone antibiotic, enabling precise workflows in antibacterial resistance studies and bone metabolism research. Its dual role as a DNA gyrase inhibitor and modulator of osteoblast and chondrocyte function makes it indispensable for translational research tackling both infection and tissue biology.

• AO/PI Double Staining Kit: Practical Guide for Cell Viabilit

  2026-04-12

  The AO/PI Double Staining Kit enables researchers to rapidly and reliably distinguish live, apoptotic, and necrotic cells using dual fluorescent dyes. It is optimal for cell viability, apoptosis, and necrosis detection in cell biology workflows where clear discrimination of cell populations is essential. Use is not recommended outside fluorescence-based viability applications or when mechanistic cell death resolution beyond AO/PI signal is required.

• TMRE Mitochondrial Membrane Potential Assay Kit: Precision f

  2026-04-11

  The TMRE mitochondrial membrane potential assay kit empowers researchers to quantify mitochondrial health with exceptional sensitivity and throughput. Its robust controls, high sample capacity, and compatibility with apoptosis research make it a gold standard for mitochondrial function analysis and cell health studies.

• Tivozanib (AV-951): Applied Strategies for In Vitro Oncology

  2026-04-11

  Tivozanib (AV-951) transforms in vitro cancer research with unmatched selectivity for VEGFR inhibition, enabling more precise modeling of anti-angiogenic therapy efficacy. This guide delivers validated protocol enhancements, actionable troubleshooting tips, and practical insights for maximizing experimental reliability using APExBIO's high-purity Tivozanib.

• Cefoperazone Sodium Salt: Broad Spectrum Antibacterial Wo...

  2026-04-10

  APExBIO’s Cefoperazone (sodium salt) delivers unmatched β-lactamase stability and robust efficacy in both in vitro and in vivo models, particularly against gram-negative resistance. This article details advanced workflows, practical troubleshooting, and strategic applications, ensuring consistent, high-impact results in antimicrobial research.

• BIRB 796: Highly Selective p38α MAPK Inhibitor for Advanc...

  2026-04-09

  BIRB 796 (Doramapimod) transforms inflammation, apoptosis, and cytokine signaling research through its dual-action, allosteric inhibition of p38α MAPK. Its unparalleled selectivity and robust workflow integration—especially in apoptosis assays and arthritis models—make it the gold standard for dissecting p38 MAPK signaling with precision and reproducibility.

• Translating MAPK/ERK Pathway Insights: U0126 as a Keyston...

  2026-04-08

  This thought-leadership article explores how U0126, a selective non-ATP-competitive MEK1/2 inhibitor, transforms translational research across cancer biology, neurobiology, and autophagy by enabling precise MAPK/ERK pathway modulation. Drawing from mechanistic insights, pivotal published evidence, and an evolving competitive landscape, the article offers strategic guidance for researchers aiming to bridge molecular understanding and clinical impact.

466 records 22/32 page Previous Next First page 上5页 2122232425 下5页 Last page